Authors: MANSECK A PILARSKY C FROSCHERMAIER S MENSCHIKOWSKI M WIRTH MP

Citation: A. Manseck et al., DIAGNOSTIC-SIGNIFICANCE OF PROSTATE-SPECIFIC ANTIGEN VELOCITY AT INTERMEDIATE PSA SERUM LEVELS IN RELATION TO THE STANDARD-DEVIATION OF DIFFERENT TEST SYSTEMS, Urologia internationalis, 60(1), 1998, pp. 25-27

Authors: OEHLSCHLAGER S ALBRECHT S PILARSKY C WIRTH MP

Citation: S. Oehlschlager et al., DETERMINATION OF SERUM AND URINE OXALATE AND OXALATE CONCENTRATIONS OF RED-BLOOD-CELLS BY CHEMILUMINESCENCE IN IDIOPATHIC CALCIUM-OXALATE NEPHROLITHIASIS, The Journal of urology, 159(5), 1998, pp. 671-671

Authors: WIRTH MP PILARSKY C

Citation: Mp. Wirth et C. Pilarsky, THE VALUE OF THE PROSTATE-SPECIFIC ANTIGE N (PSA) FOR THE CONTROL OF TREATMENT OF PROSTATE CARCINOMA, Der Urologe, 34(4), 1995, pp. 297-302

Authors: PARCZYK K PILARSKY C RACHEL U KOCHBRANDT C

Citation: K. Parczyk et al., GP80 (CLUSTERIN, TRPM-2) MESSENGER-RNA LEVEL IS ENHANCED IN HUMAN RENAL CLEAR-CELL CARCINOMAS, Journal of cancer research and clinical oncology, 120(3), 1994, pp. 186-188

Authors: PILARSKY C HAASE W KOCHBRANDT C

Citation: C. Pilarsky et al., STABLE EXPRESSION OF GP80 (TRPM-2, CLUSTERIN), A SECRETORY PROTEIN IMPLICATED IN PROGRAMMED CELL-DEATH, IN TRANSFECTED BHK-21-CELLS, Biochimica et biophysica acta, 1179(3), 1993, pp. 306-310